Parkinson Disease, Secondary (diagnostic imaging) < Parkinson Disease, Secondary (drug therapy) < Parkinson Disease, Secondary (enzymology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]

Ident.	Authors (with country if any)	Title
000014 (1999)	A F Miranda [Canada] ; M A Sutton ; R J Beninger ; K. Jhamandas ; R J Boegman	Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
000020 (1999)	R. Grondin [Canada] ; P J Bédard ; A. Hadj Tahar ; L. Grégoire ; A. Mori ; H. Kase	Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.
000095 (2000)	F. Calon [Canada] ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
000168 (2001)	C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O Poulter	Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
000332 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000335 (1992)	E. Pourcher [Canada] ; B. Gomez-Mancilla ; P J Bédard	Ethosuximide and tremor in Parkinson's disease: a pilot study.
000336 (1992)	B. Gomez-Mancilla [Canada] ; J F Latulippe ; R. Boucher ; P J Bédard	Effect of ethosuximide on rest tremor in the MPTP monkey model.
000463 (1992)	B. Gomez-Mancilla [Canada] ; P J Bédard	Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys.
000657 (1991)	B. Gomez-Mancilla [Canada] ; P J Bédard	Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
000864 (2008)	Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Richard Williams ; Peter Schieldrop ; Rahul Manchanda ; Ashok Malla ; Raj Harricharan	Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
000A16 (1991)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.
000B21 (2009)	Mallika Somayajulu-Ni U [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Marianna Sikorska [Canada] ; Ts Sridhar [Canada, Inde] ; Anca Matei [Canada] ; Henryk Borowy-Borowski [Canada] ; Siyaram Pandey [Canada]	Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10
000F94 (2012)	Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel Cyr	Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
001013 (2011)	Deepak Gupta [Canada] ; Abraham Kuruvilla	Vascular parkinsonism: what makes it different?
001133 (1990)	C. Rouillard [Canada] ; P J Bédard ; T. Di Paolo	Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
001353 (2013)	James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
001374 (2014)	Nicolas Morin [Canada] ; Vincent A. Jourdain [Canada] ; Thérèse Di Paolo [Canada]	Modeling dyskinesia in animal models of Parkinson disease.
001F19 (2016)	Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]	Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
002316 (1988)	E C Wolters [Canada] ; J C Kebabian ; M. Guttman ; E. Mak ; B D Pate ; D B Calne	A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys.
002362 (1987)	S. Gauthier [Canada] ; L. Gauthier	Current status of levodopa therapy in idiopathic Parkinson's disease.
002367 (1987)	M. El-Awar [Canada] ; M. Freedman ; P. Seeman ; L. Goldenberg ; J. Little ; P. Solomon	Response of tardive and L-dopa-induced dyskinesias to antidepressants.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease, Secondary (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (drug therapy)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022